期刊文献+

不同成骨诱导体系对MC3T3-E1成骨分化的影响

Effects of Different Osteogenic Induction Systems on Osteogenic Differentiation of MC3T3-E1 Cells
下载PDF
导出
摘要 目的:明确前成骨细胞MC3T3-E1最佳体外成骨诱导体系。方法:构建不同成骨诱导体系,分别为A组地塞米松0.1μmol/L、抗坏血酸50μg/mL及β-甘油磷酸钠10 mmol/L;B组地塞米松0.01μmol/L、抗坏血酸50μg/mL及β-甘油磷酸钠10 mmol/L;C组地塞米松1μmol/L、抗坏血酸50μg/mL及β-甘油磷酸钠10 mmol/L;D组抗坏血酸50μg/mL及β-甘油磷酸钠10 mmol/L;E组抗坏血酸100μg/mL及β-甘油磷酸钠5 mmol/L。对MC3T3-E1进行为期7 d、14 d的体外成骨诱导,通过碱性磷酸酶染色、茜素红染色对在不同成骨诱导体系作用下MC3T3-E1成骨分化的影响进行分析,通过RT-qPCR检测成骨分化相关基因ALP、Runx2、COL-1、OCN、OPN表达水平,比较不同成骨诱导体系的诱导性能。结果:B、D和E组茜素红定量最优,差异具有统计学意义(P<0.05),诱导7 d的RT-qPCR结果显示C组ALP、Runx2、COL-1的基因表达量最高(P<0.05)。诱导14 d的RT-qPCR结果显示:OCND组表达最高(P<0.05)。结论:地塞米松和抗坏血酸的浓度均对MC3T3-E1的成骨分化产生影响,C组1μmol/L地塞米松、50μg/mL抗坏血酸与10 mmol/Lβ-甘油磷酸钠早期成骨更佳,选择其作为早期成骨验证,D组50μg/mL抗坏血酸与10 mmol/Lβ-甘油磷酸钠晚期成骨更佳,但综合考虑,建议B组0.01μmol/L地塞米松、50μg/mL抗坏血酸与10 mmol/Lβ-甘油磷酸钠成骨诱导体系用于MC3T3-E1体外晚期成骨研究。 Objective:To determine the optimal osteogenic induction system in vitro for MC3T3-E1 osteoblasts.Methods:Different osteogenic induction systems were constructed,which were dexamethasone 0.1μmol/L,ascorbic acid 50μg/mL,andβ-sodium glycerophosphate 10 mmol/L in group A;dexamethasone 0.01μmol/L,ascorbic acid 50μg/mL,andβ-sodium glycerophosphate 10 mmol/L in group B;dexamethasone 1μmol/L,ascorbic acid 50μg/mL,andβ-sodium glycerophosphate 10 mmol/L in group C;ascorbic acid 50μg/mL andβ-sodium glycerophosphate 10 mmol/L in Group D;and ascorbic acid 100μg/mL andβ-sodium glycerophosphate 5 mmol/L in Group E.MC3T3-E1 cells were induced in vitro for 7 days and 14 days.The effects of alkaline phosphatase staining and alizarin red staining on osteogenic differentiation of MC3T3-E1 were analyzed.The expression levels of osteogenic differentiation related genes(ALP,Runx-2,COL-1,OCN,OPN)were detected by RT-qPCR.Results:There was a significant difference in the optimal quantification of alizarin among groups B,D,and E(P<0.05).The PCR results at 7 days after induction showed that the gene expression levels of ALP,Runx-2,and COL-1 in group C were the highest(P<0.05).PCR results at 14 days after induction showed that the expression of OCN in Group D was the highest(P<0.05).Conclusion:The concentrations of dexamethasone and ascorbic acid have an effect on the osteogenic differentiation of MC3T3-E1 cells.Group C was better for early osteogenesis and Group D was better for late osteogenesis.However,in comprehensive consideration,Group B is recommended for late osteogenesis.
作者 管馨 陈安琪 赖颖真 吴勇敏 翁鑫泽 王伟新 雷奕宣 GUAN Xin;CHEN Anqi;LAI Yingzhen;WU Yongmin;WENG Xinze;WANG Weixin;LEI Yixuan(Department of Stomatology,Xiamen Medical College,Engineering Research Center of Stomatological Biomaterials,Fujian Province University,Xiamen 361023,China.)
出处 《口腔医学研究》 CAS CSCD 北大核心 2024年第4期304-309,共6页 Journal of Oral Science Research
基金 大学生创新创业训练计划立项(国家级)(编号:202312631004) 福建省自然科学基金面上项目(编号:2022J011408) 厦门医学院校级科研立项(编号:K2023-01)。
关键词 MC3T3-E1 成骨分化 诱导体系 MC3T3-E1 osteogenic differentiation inducement system
  • 相关文献

参考文献11

二级参考文献82

  • 1余勤,连俊兰,王艳,郭莹,万海同.大鼠骨髓间质干细胞体外培养扩增及生物学特性研究[J].浙江中医药大学学报,2006,30(2):189-192. 被引量:18
  • 2Pit tenger MF, Mackay AM, Beck SC, et al. Muhilinage potential of adult human mesenchymal stem cell. Science, 1999,284 (5411) : 143-147.
  • 3Kalu DN, Liu CC. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology, 1989,124(1) :7-16.
  • 4Kajkenova O, Lecka-Czemik B. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res, 1997, 12(11):1772-1779.
  • 5Bergman RJ, Gazit D, Kahn AJ, et al. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res, 1996,11 (5) :568- 577.
  • 6Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science, 2001, 292: 1160-1164.
  • 7Mundy GR. Statins and their potential for osteoporosis. Bone, 2001, 29 : 495-497.
  • 8Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science,1999,286: 1946-1949.
  • 9Sugiyama M, Kodama T, Konishi K, et al. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma ceils. Biochem Biophys Res Commun, 2000, 271 : 688-692.
  • 10Ohnaka K, Shimoda S, Nawata H, et al. Pitavastatin enhanced BMP-2 and osteocalcon expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun, 2001, 287 : 337-342.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部